RecruitingPhase 4NCT04265430

Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors

Serial Magnetic Resonance Imaging of Longitudinal Radiotherapy-Attributable Normal Tissue Injury


Sponsor

M.D. Anderson Cancer Center

Enrollment

425 participants

Start Date

Sep 17, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

This phase IV trial studies how well serial magnetic resonance imaging (MRI) after radiation therapy works in predicting radiation-induced changes in the normal tissue of patients with oral cavity or skull base tumors. Performing MRIs after radiation therapy for patients with oral cavity or skull base tumors may help to predict osteoradionecrosis (a change in non-cancerous tissue).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is using advanced MRI scans to track changes in normal tissues (like jaw bone and soft tissues) during and after radiation treatment in patients with cancers of the mouth, throat, or skull base, to better predict and prevent radiation-related complications such as bone damage (osteonecrosis). **You may be eligible if:** - You are 18 or older and in good general health - You have a confirmed cancer of the oral cavity, oropharynx, or skull base and are about to receive radiation therapy - OR you have already had radiation and developed a complication called osteoradionecrosis (ORN) or medication-related osteonecrosis of the jaw (MRONJ) **You may NOT be eligible if:** - You are unable to tolerate the specific types of MRI scans used in this study (DW-MRI or DCE-MRI) - You have other conditions preventing MRI participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERContrast Agent

Given IV

PROCEDUREMagnetic Resonance Imaging

Undergo MRI

OTHERQuality-of-Life Assessment

Ancillary studies

OTHERQuestionnaire Administration

Ancillary studies


Locations(1)

M D Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04265430


Related Trials